Acquired Hyperostosis Syndrome: Clinical Trials

2 trials for Acquired Hyperostosis Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 unknown. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 1, Unknown 1
Phase 31Recruiting 1

Follow Acquired Hyperostosis Syndrome: new trials by email Literature Review of Acquired Hyperostosis Syndrome trials Research Report on Acquired Hyperostosis Syndrome

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome
Etanercept, Placebo - SAPHO Syndrome
Phase 2 / Phase 3RecruitingNational Institute of Geriatrics, Rheumatology and Rehabilitation, Poland602024-09-042026-04-13
Chronic Non-bacterial Osteomyelitis Treated With Pamidronate
Pamidronatdinatrium, Natrium chloride 9mg/ml - Immune System Disease, Musculoskeletal Disease
Phase 2UnknownUniversity of Aarhus322015-10-012016-11-16

Narrower conditions

Chronic recurrent multifocal osteomyelitis (1)  ·  Immune System Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Osteitis (1)

Broader conditions

Bone Diseases (2)  ·  Bone Diseases, Developmental (2)  ·  Osteochondrodysplasias (2)  ·  Musculoskeletal Diseases (1)

Interventions

Etanercept (1)  ·  Pamidronate (1)

Sponsors

National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland (1)  ·  University of Aarhus (1)

Countries

Denmark (1)  ·  Poland (1)

Top investigators

Caroline Marie Andreasen, MD (1)

Results publications

PMID 32484386